Industry Developments

Recently listed Mexican drugmaker Genomma Lab Internacional has acquired the brand Unigastrozol along with the related rights and registrations from Unipharm de Mexico . The drug... 2008-08-05

In a move aimed at lowering pharmaceutical prices in Mexico, President Felipe Calderón has pledged to end the requirement for pharmaceutical companies that sell products in Mexico... 2008-08-05

The US FDA has issued a "not-approvable" letter for Schering-Plough's Bridion (sugammadex), a drug used to reverse the effects of anesthesia.

US-based Vanguard Pharmaceutical has signed a contract to sell the generics portfolio of India's Arbro Pharmaceutical in Latin America and the Caribbean. The deal gives Vanguard exclusive... 2008-08-04

According to the head of the US FDA's Office of Generic Drugs, Gary Buehler, the average time the agency took to evaluate a generic drug application was 19 months in 2007, more than... 2008-08-01

Ranbaxy Pharmaceuticals has announced that it has launched a generic 40 mg version of ulcer drug Prilosec (omeprazole) in the US under an agreement with AstraZeneca . The drug... 2008-07-30

Reuters has reported that 1,013 people died in 2005-2007 after overdosing on the powerful pain killer fentanyl. Chicago alone witnessed 349 deaths, followed by Philadelphia with 269,... 2008-07-29

US-based Emergent Biosolutions has announced a joint venture with the University of Oxford for the development of a tuberculosis (TB) vaccine. The Oxford-Emergent Tuberculosis Consortium... 2008-07-29

Reuters has reported that General Electric (GE) will acquire medical device maker Vital Signs for US$860mn.

According to the New York Times, the US Food and Drug Administration (FDA) is expected to release an advisory recommending that doctors conduct a genetic test on patients with HIV/AIDS... 2008-07-28